Related Experiment Videos
Phage therapy: past history and future prospects.
1Exponential Biotherapies, Inc., Port Washington, NY 11050, USA.
Archivum Immunologiae Et Therapiae Experimentalis
|December 22, 1999
Summary
Bacteriophages (phages) show promise as antibacterial agents. Modern research, using improved methods, is re-evaluating phage therapy for drug-resistant bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Therapeutics
Background:
- Bacteriophages (phages) are bacterial viruses with potential as antibacterial agents.
- Early phage therapy (1920s-1950s) was limited by phage physiology, technology, and inadequate scientific methods.
- Recent animal models and clinical reports show phage efficacy against drug-resistant infections.
Purpose of the Study:
- To re-evaluate phage therapy using modern technologies and placebo-controlled designs.
- To explore phage therapy as a standalone or adjunct treatment for antibiotic-resistant infections.
Main Methods:
- Review of historical phage therapy trials and limitations.
- Analysis of recent animal model studies demonstrating phage efficacy.
- Evaluation of clinical reports on phage therapy for human infections.
Main Results:
- Historical limitations included narrow host range, rapid clearance, lack of lysogeny understanding, and poor study design.
- Well-controlled animal studies confirm phages can treat fatal infections.
- Eastern European clinical reports suggest effectiveness against drug-resistant human infections.
Conclusions:
- Phage therapy presents a viable option for treating drug-resistant bacterial infections.
- Modern, rigorous scientific approaches are essential for validating phage therapy.
- Phage therapy can be used alone or with antibiotics, depending on bacterial susceptibility.